Basiliximab

ATC L04AC02 · 11 markets · 19 records

Basiliximab 11 markets · 19 records Forms

GB 4 records · 2 strengths

US 3 records · 2 strengths

  • 10 mg/2.5 mLinjectionSimulectManufacturer: Novartis Pharma Stein AG
  • 20 mg/5 mLinjectionSimulect

AU 3 records · 3 strengths

  • 20 mginjectionSIMULECT basiliximab (rmc) 20mg powder for injection vial also in GB·FR·CN unknown
  • 20 mgunknownSIMULECT basiliximab (rmc) 20mg powder for injection vial and diluent ampoule unknown
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

FR 2 records · 2 strengths

CA 1 records · 1 strengths

SG 1 records · 1 strengths

  • 20 mg/vialinjectionSIMULECT FOR INJECTION 20 mg/vial

CN 1 records · 1 strengths

TW 1 records · 1 strengths

HK 1 records · 1 strengths

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名SIMULECT POWDER FOR INJ 20MG ×1

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    EU 1 records · 1 strengths

    EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

      1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
      The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

      Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

      A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.